Never miss a story

Get subscribed to our newsletter


×
Breast cancer patients who consume supplements during chemotherapy have chances of recurring and deaths. Pixabay

Patients with breast cancer who use supplements during chemotherapy may be at an increased risk of recurrence and death, a new study suggests.

Use of dietary supplements that boost levels of antioxidants, iron, vitamin B12 and omega-3 fatty acids appeared to lower the effectiveness of chemotherapy, researchers report in the Journal of Clinical Oncology.


“From this study and others in the literature, it seems that it may not be wise to take supplements during chemotherapy,” said Christine Ambrosone, chair of cancer prevention and control, and senior vice president for population sciences at the Roswell Park Comprehensive Cancer Center in Buffalo, New York.

“It’s thought that antioxidants might interfere with the ability of chemotherapy to kill cancer cells,” Ambrosone explained. “One way chemotherapy works is by generating lots of oxidative stress. The thinking is that antioxidants may block oxidative stress and make chemotherapy less effective.”

Doctors have been advising patients for a number of years not to take antioxidants during chemotherapy, Ambrosone said.

“But there was no strong empirical data for that recommendation,” she added.

To take a closer look at whether supplement use might impact chemotherapy’s effectiveness, Ambrosone and colleagues analyzed data from the Diet, Exercise, Lifestyle and Cancer Prognosis study, which was piggybacked onto a trial designed to determine the best dose and schedule of chemotherapy drugs.


Breast cancer patients taking B12 were 83% more likely to experience a recurrence and 22% more likely to die. Pixabay

Participants were queried about their use of supplements at the outset and during treatment, and about their lifestyle, diet and exercise habits.

The researchers focused on 1,134 patients who filled out the surveys and followed them for a median of six years. In this particular group of patients, supplement use was much lower than is typical, Ambrosone said, with 20% taking supplements prior to starting chemo and 13% during the treatments.

After accounting for other factors that might increase the risk of recurrence or death, they found patients who took any antioxidant at the outset and during chemotherapy — including carotenoids, Coenzyme Q10 and vitamins A, C, and E — were 41% more likely to have their breast cancer return and 40% more likely to die during follow-up compared to patients using no supplements.

The findings were similar for most individual antioxidants taken before and during chemo, particularly vitamin A. But for the others, the results were not statistically significant, meaning the differences were too small to rule out the possibility they were due to chance. Ambrosone attributes this to the small numbers of patients taking these supplements.


A patient receives chemotherapy treatment for breast cancer at the Antoine-Lacassagne Cancer Center. VOA

B12, iron

Those taking B12 and iron supplements were at greater risk of recurrence and those results were statistically significant.

Women taking B12 were 83% more likely to experience a recurrence and 22% more likely to die during follow-up compared to those who did not take those supplements. Women taking omega-3 supplements before and during chemo had a 67% higher likelihood of recurrence and those taking iron supplements were 79% more likely to experience a recurrence.

Previous research has suggested that iron “can play a role in both cancer initiation as well as promotion,” Ambrosone said.

Dr. Amy Tiersten welcomed the new research.

“I am really happy to see that this study has been done,” said Tiersten, a professor of medicine, oncology and hematology at the Icahn School of Medicine at Mount Sinai in New York City. “For years we have been cautioning patients about the use of vitamins, in particular anti-oxidants, during chemotherapy for breast cancer.”

Also Read- Here’s how Climate Change Has Affected Livelihood in Africa

“There has been ongoing theoretical concern about the fact that while antioxidants may protect normal cells from the toxic effects of chemo, we don’t know that they don’t also protect the cancer cells,” Tiersten said in an email. “Now we have solid data to back up that concern. I am a bit surprised by the magnitude of the effect, a 41% increase in the risk of recurrence for patients taking these supplements. I have always told patients on chemotherapy that the best way to get their vitamins is through a well-balanced diet, and will continue to do so given these data.” (VOA)


Popular

File

Bangladesh over the years show that the state has failed in its duty to protect minorities

By- Salil Gewali

If humanity is hurt, God is hurt.

Religion without compassion might give way to hatred. Compassion with a "self-interest" motive is completely irreligious. But of late, some of the religions have departed from those basic human values. Love and compassion are for only those who follow their "specific" faith. Very sadly, the religions are up as trading commodities in the world of proselytization. Better preachers attract more followers. Of course, no issue if they are not vying for their religious "supremacy". But the ground reality is utterly different. The claim for exclusive supremacy has become the first commandment --- a real bone of contention among the existing religions. In the name of religion, we have polluted our minds. we have corrupted our souls. We have also gone so much astray that God must have now shut his gateway to heaven!

Keep Reading Show less
File

The Aruba villa has great interiors, an outdoor facility, amazing bedrooms, clean bathrooms and huge living space.

By- Your Service

Taking out time for family has become very difficult as people are pretty busy in daily life and find very little time to spend with their loved ones. Planning a family vacation is an excellent way through which the whole family can step away from their daily life and have fun. You can find many destinations for a family vacation, but there is no place that can beat Aruba.

Keep Reading Show less
Photo by Flickr

Milky Way galaxy as seen from Chitkul Valley

NASA's Chandra X-ray Observatory has for the first time spotted signs of a planet transiting a star outside of the Milky Way galaxy, opening up a new avenue to search for exoplanets at greater distances than ever before.

The possible exoplanet -- or planets outside of our Solar System -- candidate is located in the spiral galaxy Messier 51 (M51), also called the Whirlpool Galaxy because of its distinctive profile, NASA said in a statement.

Astronomers have, so far, found all other known exoplanets and exoplanet candidates in the Milky Way galaxy, almost all of them less than about 3,000 light-years from Earth.

An exoplanet in M51 would be about 28 million light-years away, meaning it would be thousands of times farther away than those in the Milky Way, NASA said.

"We are trying to open up a whole new arena for finding other worlds by searching for planet candidates at X-ray wavelengths, a strategy that makes it possible to discover them in other galaxies," said Rosanne Di Stefano of the Center for Astrophysics at Harvard and Smithsonian (CfA) in Cambridge, Massachusetts, who led the study.

The findings are published in the journal Nature Astronomy.

The exoplanet candidate was spotted in a binary system called M51-ULS-1, located in M51. This binary system contains a black hole or neutron star orbiting a companion star with a mass about 20 times that of the Sun. The X-ray transit they found using Chandra data lasted about three hours, during which the X-ray emission decreased to zero.

Based on this and other information, the team estimates the exoplanet candidate in M51-ULS-1 would be roughly the size of Saturn and orbit the neutron star or black hole at about twice the distance of Saturn from the Sun.

The team looked for X-ray transits in three galaxies beyond the Milky Way galaxy, using both Chandra and the European Space Agency's XMM-Newton. Their search covered 55 systems in M51, 64 systems in Messier 101 (the "Pinwheel" galaxy), and 119 systems in Messier 104 (the "Sombrero" galaxy).

However, more data would be needed to verify the interpretation as an extragalactic exoplanet. One challenge is that the planet candidate's large orbit means it would not cross in front of its binary partner again for about 70 years, thwarting any attempts for a confirming observation for decades, NASA said.

Named in honor of the late Indian-American Nobel laureate, Subrahmanyan Chandrasekhar, the Chandra X-ray Observatory is the world's most powerful X-ray telescope. It has eight times greater resolution and is able to detect sources more than 20-times fainter than any previous X-ray telescope.

Known to the world as Chandra (which means "moon" or "luminous" in Sanskrit), Chandrasekhar was widely regarded as one of the foremost astrophysicists of the twentieth century. (IANS/JB)


Keep reading... Show less